Security key
14757U109
- Security type / class
- Equity / COM
- Total 13F shares
- 46,671,130
- Total 13F value
- $72,329,878
- Share change
- -6,399,922
- SEC-reported price per share
- $1.55
- Number of holders
- 65
- Value change
- -$13,539,472
- Number of buys
- 31
- Number of sells
- 53
Report period
Q2 2021
Institutions
65
Top holders
10
CASI full security history
Ownership snapshot
Full 13F holder table
CASI Pharmaceuticals, Inc. SEC filings
CASI Pharmaceuticals, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of CASI - CASI PHARMACEUTICALS INC - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Consonance Capital Manage...
Disclosed value leader
Consonance Capital Manage...
Comparable rows
0/15
Latest evidence
31 Mar 2021
13F
Highest disclosed value: $25,298,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Consonance Capital Management LP has the largest disclosed position value at $25.3M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Consonance Capital Management LP's linked filing trail.
Disclosed position value
Top 5
Consonance Capital Management LP
$25.3M
FEDERATED HERMES, INC.
$24.36M
IDG-Accel China Growth Fund III A...
$19.14M
VANGUARD GROUP INC
$10.14M
BlackRock Finance, Inc.
$9.62M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Consonance Capital Management LP |
13F
Company
|
—
denominator unverified
|
$25,298,000
10,540,715 shares
|
— | 31 Mar 2021 |
| FEDERATED HERMES, INC. |
13F
Company
|
—
denominator unverified
|
$24,360,000
10,150,000 shares
|
— | 31 Mar 2021 |
| IDG-Accel China Growth Fund III Associates L.P. |
13F
Company
|
—
denominator unverified
|
$19,136,000
7,973,536 shares
|
— | 31 Mar 2021 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$10,137,000
4,223,694 shares
|
— | 31 Mar 2021 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$9,618,000
4,006,960 shares
|
— | 31 Mar 2021 |
| Wellington Shields Capital Management, LLC |
13F
Company
|
—
denominator unverified
|
$5,356,000
2,231,765 shares
|
— | 31 Mar 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
65
Shares
46,671,130
Rows available
65
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
80
Q2 2021 holders
65
Holder diff
-15
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 value | Q2 2021 value | Value change | Value Chg % |
|---|